{
    "clinical_study": {
        "@rank": "139401", 
        "arm_group": [
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "No Intervention", 
                "description": "Only saline is given."
            }, 
            {
                "arm_group_label": "+ Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Endotoxin is given + Placebo (Saline)"
            }, 
            {
                "arm_group_label": "+ amino acids", 
                "arm_group_type": "Active Comparator", 
                "description": "Endotoxin is given + amino acids (intravenously)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to investigate the metabolic effects during acute inflammation\n      with and without the nutritional supplement of amino acids.\n\n      E. Coli Endotoxin (LPS, lipopolysaccharide) is used to initiate an inflammatory response.\n\n      The study is an interventional randomized placebo study including 8 healthy male subjects.\n      Each subject participates 3 times (different days) and are given one of following\n      interventions:\n\n        -  Placebo (NaCl)\n\n        -  Endotoxin, US standard reference E.Coli + Placebo (NaCl)\n\n        -  Endotoxin, US standard reference E.Coli + Amino acids (intravenously)\n\n      It is our hypothesis that the nutritional intervention during acute inflammation plays an\n      important role in lipid and protein metabolism."
        }, 
        "brief_title": "The Effects of Amino Acid Supplement During Acute Inflammation.", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Febrile Illness Acute", 
            "Inflammation", 
            "Metabolic Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Metabolic Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male gender\n\n          -  20<BMI<30\n\n          -  Age > 25 years old\n\n          -  Written consent before starting the study\n\n        Exclusion Criteria:\n\n          -  Allergy for soya products ore egg\n\n          -  Diabetes\n\n          -  Epilepsy\n\n          -  Infection\n\n          -  Immune defects\n\n          -  Heart disease\n\n          -  Dysregulated hypertension\n\n          -  Participating in other trials using radioactive tracers or x-rays the last year."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01705782", 
            "org_study_id": "2012-410-12"
        }, 
        "intervention": {
            "arm_group_label": [
                "+ Saline", 
                "+ amino acids"
            ], 
            "intervention_name": "E. coli endotoxin, US standard", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aarhus C", 
                    "country": "Denmark", 
                    "state": "Jylland", 
                    "zip": "8000"
                }, 
                "name": "Medical Department MEA, NBG, Aarhus University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "3", 
        "official_title": "Metabolic Effects of Endotoxin Induced Acute Inflammation in Healthy Young Men With and Without Supplement of Amino Acids.", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Protein catabolism is measured with amino acid tracer techniques comparing radioactive marked amino acids from blood samples.", 
            "measure": "Protein catabolism during acute illness", 
            "safety_issue": "No", 
            "time_frame": "After 6 hours intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01705782"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Aarhus", 
            "investigator_full_name": "Nikolaj Fibiger Rittig", 
            "investigator_title": "MD (medical graduate) and Ph.d.-student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "A muscle + fat biopsy are taken twice during the intervention to focus on the local effects in these tissues.", 
                "measure": "The local effects on muscle and fat tissue", 
                "safety_issue": "No", 
                "time_frame": "At 2 hours and 4,5 hours"
            }, 
            {
                "description": "Lipid and glucose metabolism are measured with tracer techniques with radioactive marked glucose + lipid.", 
                "measure": "Other systemic metabolic effects during acute illness", 
                "safety_issue": "No", 
                "time_frame": "6 hours"
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}